SCHEMBL17786643

SCHEMBL17786643

CC(C)(C)N(CC#N)Cc1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 1/20 0.45
NR1D1 P20393 1/20 0.40
SLC6A4 P31645 3/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A3 Q01959 2/20 0.39
HTR2A P28223 1/20 0.39
HRH1 P35367 1/20 0.39
HTR2B P41595 1/20 0.39
CHRNA4 P43681 1/20 0.39
ALDH1A1 P00352 3/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.35
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
AOC3 Q16853 1/20 0.33
LMNA P02545 1/20 0.33
KCNH2 Q12809 1/20 0.33
P2RX7 Q99572 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786046 0.83 PYCR1 (0.45) PYCR1ALDH1A1AOC3MAOAMAOB
SCHEMBL19327561 0.83 PYCR1 (0.45) PYCR1ALDH1A1HTTKDM4EMAOB
SCHEMBL1024967 0.82 ALDH1A1 (0.47) PYCR1ALDH1A1HTTPOLBKMT2A
SCHEMBL15307297 0.74 SLC6A4 (0.40) PYCR1SLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL5703569 0.70 NR1D1 (0.53) PYCR1NR1D1SLC6A4SLC6A2SLC6A3
SCHEMBL10294049 0.70 PYCR1 (0.48) PYCR1SLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL11405433 0.67 ALDH1A1 (0.61) PYCR1NR1D1SLC6A4ALDH1A1HTT
SCHEMBL22443393 0.67 ALDH1A1 (0.42) PYCR1ALDH1A1HTTRAB9APOLB
SCHEMBL11575007 0.66 SLC6A4 (0.52) PYCR1SLC6A4SLC6A2SLC6A3HTR2A
SCHEMBL2823833 0.64 SLC6A4 (0.55) PYCR1SLC6A4SLC6A2SLC6A3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10829453-B2 Antagonists of the kappa opioid receptor UNIVERSITY OF KANSAS (US) 2020-11-10 US disclosed
US-20190300486-A1 ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2019-10-03 US disclosed
US-10118896-B2 Antagonists of the kappa opioid receptor UNIVERSITY OF KANSAS (US) 2018-11-06 US disclosed
US-20170260141-A1 ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2017-09-14 US disclosed
WO-2016086149-A1 ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR UNIVERSITY OF KANSAS (US) 2016-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829453-B2 Antagonists of the kappa opioid receptor OPRK1, OPRD1, OPRL1 PYCR1 2804/4885NR1D1 133/4885SLC6A4 209/4885
US-10118896-B2 Antagonists of the kappa opioid receptor OPRK1, OPRD1, OPRL1 PYCR1 2804/4885NR1D1 133/4885SLC6A4 209/4885
US-20190300486-A1 ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR OPRK1, OPRD1, OPRL1 PYCR1 2804/4885NR1D1 133/4885SLC6A4 209/4885
US-20170260141-A1 ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR OPRK1, OPRD1, OPRL1 PYCR1 2804/4885NR1D1 133/4885SLC6A4 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.